Highlights and Quick Summary
- Change in other assets and liabilities for the quarter ending June 30, 2023 was $-21 Million (a 366.67% increase compared to previous quarter)
- Year-over-year quarterly Change in other assets and liabilities increased by 153.01%
- Annual Change in other assets and liabilities for 2022 was $-10.3 Million (a -57.26% decrease from previous year)
- Annual Change in other assets and liabilities for 2021 was $-24.1 Million (a 33.89% increase from previous year)
- Annual Change in other assets and liabilities for 2020 was $-18 Million (a -53.96% decrease from previous year)
- Twelve month Change in other assets and liabilities ending June 30, 2023 was $-19.1 Million (a -1161.11% decrease compared to previous quarter)
- Twelve month trailing Change in other assets and liabilities decreased by -175.79% year-over-year
Trailing Change in other assets and liabilities for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-19.1 Million | $1.8 Million | $-10.3 Million | $25.2 Million |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in other assets and liabilities of Emergent Biosolutions Inc.
Most recent Change in other assets and liabilitiesof EBS including historical data for past 10 years.Interactive Chart of Change in other assets and liabilities of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Change in other assets and liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-21.0 | $-4.5 | – | – | – |
| 2022 | $14.7 | $-8.3 | $-0.1 | $-16.6 | $-10.3 |
| 2021 | $50.2 | $-71.9 | $-1.8 | $-0.6 | $-24.1 |
| 2020 | $52.8 | $-53.9 | $-2.1 | $-14.8 | $-18.0 |
| 2019 | $-2.6 | $-8.0 | $-11.9 | $-16.6 | $-39.1 |
| 2018 | $-0.1 | $-3.7 | $5.0 | $-14.2 | $-13.0 |
| 2017 | $-0.55 | $-5.46 | $5.91 | $11.4 | $11.3 |
| 2016 | $6.89 | $-3.96 | $3.53 | $-3.96 | $2.5 |
| 2015 | $1.41 | $-0.2 | $4.9 | $-0.32 | $5.79 |
| 2014 | $2.41 | $-6.21 | $-1.02 | $-0.51 | $-5.33 |
| 2013 | $-2.95 | $-1.76 | $-1.45 | $-0.05 | $-6.2 |
| 2012 | $0.74 | $-2.36 | – | – | $-0.59 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic